Allergy Drugs
| Product Code | GIA01342 |
| Publication Date | February 2010 |
| Publisher | Global Industry Analysts |
| Product Type | Report |
| Pages | 583 |
| ISBN Number | not applicable |
Allergy Drugs
This report analyzes the US Market for Allergy Drugs in US$ Million by the following types - Prescription Antihistamines, Prescription Corticosteroids, and OTC Allergy Drugs. Annual forecasts are provided for the period 2007 through 2015. The report profiles 109 companies including many key and niche players such as Collegium Pharmaceutical, Inc., McNeil Consumer Healthcare, Meda Pharmaceuticals, Inc., Novartis Consumer Healthcare, Inc., Schering-Plough Corp, Sepracor, Inc., and Vicks. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Contents
- I.Introduction, Methodology & Product Definitions
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- II. A US Market Report
- 1.Market Review
- Allergy - A Global Perspective
- Allergy Prevalence
- Allergy - A US Perspective
- Allergy Prevalence
- Market Overview
- Market Outlook
- Manufacturers Leverage Opportunity, Announce New Product Launches
- Zyrtec' Move to Otc Aisles Perks up Otc Sales
- Allergy Patients Turn to Complimentary Medicine
- Leading Allergy Products
- Table 1: US Allergy Drugs Market - Percentage Share Breakdown of Antihistamine Products by New Prescriptions for 2007, 2008 and 2009 (Includes Corresponding Graph/Chart)
- Table 2: US Allergy Drugs Market - Percentage Share Breakdown of Antihistamine + Decongestant Combination Products by New Prescription for 2007, 2008 and 2009 (Includes Corresponding Graph/Chart)
- Table 3: US Allergy Drugs Market - Percentage Share Breakdown of Allergy Nasal Spray Products by Total Prescriptions (in Thousands) for 2007 and 2008 (Includes Corresponding Graph/Chart)
- Table 4: US Allergy Drugs Market - Percentage Share Breakdown of Allergy Nasal Spray Products by Value Sales for 2007 and 2008 (Includes Corresponding Graph/Chart)
- 2.Allergy Overview
- Allergy: Definition
- Causes/ Factors
- Symptoms/ Triggers
- Allergic Rhinitis - A Common Allergy
- Types of Allergic Rhinitis
- Diagnosis of Allergic Rhinitis
- Treatment of Allergy
- Antihistamines
- Antihistamines - List of Select Generic Formulations and Products
- Risks/ Side Effects
- Decongestants
- Decongestants - List of Select Generic Formulations and Products
- Decongestant + Antihistamine - List of Select Generic Formulations and Products
- Risks/ Side Effects
- Corticosteroids
- Intranasal Corticosteroids - List of Select Generic Formulations and Products
- Side Effects
- Allergy Shots
- Other Medicines
- Sodium Cromoglycate
- Cromolyn Sodium
- Leukotriene Modifiers
- Glucocorticoids
- Leading Allergy Drugs
- Claritin
- Zyrtec
- Benadryl
- Pollinex® Quattro
- Cortaid
- Visine-A
- Ocean Sinus Irrigation
- Crolom Eye Drops
- 3.Product Introductions/ Approvals
- Mcneil Consumer Healthcare Launches Zyrtec for Children
- Cobalis Announces Online Launch of Anti-Allergy Product
- Collegium Pharmaceutical Obtains Fda Approval for Allernaze
- Sanofi-Aventis and Ucb Win Nda Approval for Xyzal Oral Solution
- Sepracor Launches Omnaris Nasal Spray for Seasonal and Perennial Allergies
- Sanofi Aventis Launches Allegra Orally Disintegrating Tablets
- Ranbaxy Wins Fda Approval for Generic Zyrtec
- Wockhardt Introduces Generic Cetirizine Tablets
- Hi-Tech Pharmacal Receives Fda Approval for Fluticasone Propionate
- Boca Pharmacal Wins Fda Approval for Palgic's Generic Product
- Ranbaxy Receives Fda Approval for Cetirizine Hydrochloride Oral Solution
- Perrigo and Teva Receive Fda Approval for Zyrtec-D
- Sanofi-Aventis Receives Fda Approval for Nasacort Aq® Nasal Spray
- Sanofi-Aventis and Ucb Introduce Xyzal Anti-Allergy Medication
- Sanofi-Aventis Wins Fda Approval for Allegra® Oral Suspension
- Matrixx Launches Zicam Multi-Symptom Cold & Flu Relief Products
- Ranbaxy Receives Approval to Market Claritin Reditabs' Generic
- Procter & Gamble Introduces Nyquil D
- Leiner to Launch Naproxen Cold & Sinus Private Label Allergy Products
- 4.Recent Industry Activity
- Merck Announces Business Merger Plan with Schering-Plough
- Hi-Tech Pharmacal to Acquire Ecr Pharmaceuticals
- Ibt Laboratories and Viracor Announce Merger Plan
- Lupin Acquires Rights to Collegium's Intra-Nasal Steroid
- Cobalis and Melodic Sign Agreement for Prehistin
- Patheon Receives Contract to Commercialize Allergy Drugs
- Boehringer Ingelheim Signs Agreement for Actimis Acquisition
- Perrigo Acquires US Rights to Levocetirizine Tablets
- Sciele Pharma Acquires Verus Pharmaceuticals' Allergy Injection
- Sanofi-Aventis and Johns Hopkins University Division Sign Agreement
- Pipex Announces Effective Pharmaceuticals Acquisition
- Meda to Take over American Company, Medpointe
- Private Group Proposes to Acquire Majority Interest in Inyx
- 5.Focus on Select Players
- Collegium Pharmaceutical, Inc.
- Mcneil Consumer Healthcare
- Meda Pharmaceuticals, Inc.
- Novartis Consumer Healthcare, Inc.
- Schering-Plough Corp.
- Sepracor, Inc.
- Vicks
- 6.US Market Perspective
- Table 5: US Recent past, Current & Future Analysis for Allergy Drugs by Product Segment - Prescription Antihistamines, Prescription Corticosteroids and Otc Allergy Drugs Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (Includes Corresponding Graph/Chart)
- Table 6: US Historic Review for Allergy Drugs by Product Segment - Prescription Antihistamines, Prescription Corticosteroid and Otc Allergy Drugs Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (Includes Corresponding Graph/Chart)
- Table 7: US 15-Year Perspective for Allergy Drugs by Product Segment - Percentage Breakdown of Annual Value Sales for Prescription Antihistamines, Prescription Corticosteroids and Otc Allergy Drugs Markets for Years 2003, 2009 & 2015 (Includes Corresponding Graph/Chart)
- III. Rest of World Markets
- 1.Canada
- Allergy - Overview
- Strategic Corporate Developments
- 2.Japan
- Allergy - Overview
- Product Approvals
- 3.Europe
- Allergy - Prevalence
- United Kingdom
- Allergy - Overview
- Russia
- Allergy - Overview
- Product Launch
- Strategic Corporate Developments
- Select Players
- 4.Asia-Pacific
- Allergy - Overview
- Australia and New Zealand
- China
- Market Overview
- Otc Medications - A Small, but Growing Market
- Market Analytics
- Table 8: Chinese Recent past, Current & Future Analysis for Allergy Drugs - Annual Sales Figures in US$ Million for Years 2006 through 2015 (Includes Corresponding Graph/Chart)
- India
- Market Overview
- Malaysia
- Allergy - Overview
- IV. Competitive Landscape
- Total Companies Profiled: 109 (Including Divisions/Subsidiaries - 139)
- Region/Countryplayers
- The United States
- Canada
- Japan
- Europe
- France
- Germany
- The United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific (Excluding Japan)
- Middle-East
- Africa